Evidence map›Paper›PMID 36394205›Full record

ReviewClinical and translational medicine2022

When the clock ticks wrong with COVID-19.

Silvana Papagerakis, Raed Said, Farinaz Ketabat, Razi Mahmood, Meenakshi Pundir, Liubov Lobanova, Greg Guenther, Giuseppe Pannone, Kerry Lavender, Blake R McAlpin and 3 more

Open access · goldAbstract readReview
In one paragraph

Review in Clinical and translational medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. When the clock ticks wrong with COVID-19.Clinical and translational medicine · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 3 countries.

Silvana PapagerakisLaboratory of Oral, Head and Neck Cancer - Personalized Diagnostics and Therapeutics, College of Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.ORCID 0000-0003-3846-2721
Raed SaidLaboratory of Oral, Head and Neck Cancer - Personalized Diagnostics and Therapeutics, College of Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
Farinaz KetabatLaboratory of Oral, Head and Neck Cancer - Personalized Diagnostics and Therapeutics, College of Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
Razi MahmoodLaboratory of Oral, Head and Neck Cancer - Personalized Diagnostics and Therapeutics, College of Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.ORCID 0000-0002-8179-1216
Meenakshi PundirLaboratory of Oral, Head and Neck Cancer - Personalized Diagnostics and Therapeutics, College of Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
Liubov LobanovaLaboratory of Precision Oral Health and Chronobiology, College of Dentistry, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
Greg GuentherLaboratory of Oral, Head and Neck Cancer - Personalized Diagnostics and Therapeutics, College of Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
Giuseppe PannoneAnatomic Pathology Unit, Department of Clinic and Experimental Medicine, University of Foggia, Foggia, Italy.
Kerry LavenderDepartment of Biochemistry, Microbiology and Immunology, College of Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
Blake R McAlpinLaboratories of Neuroimmunology, Department of Symptom Research, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Alain MoreauViscogliosi Laboratory in Molecular Genetics of Musculoskeletal Diseases, Centre Hospitalier Universitaire (CHU) Sainte-Justine Research Center, Montreal, Quebec, Canada.
Xiongbiao ChenDivision of Biomedical Engineering, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
Petros PapagerakisDivision of Biomedical Engineering, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
University of Saskatchewan · CACentre Hospitalier Universitaire Sainte-Justine · CAThe University of Texas MD Anderson Cancer Center · USUniversity of Foggia · ITUniversity of Michigan · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a member of the coronavirus family that causes the novel coronavirus disease first diagnosed in 2019 (COVID-19). Although many studies have been carried out in recent months to determine why the disease clinical presentations and outcomes can vary significantly from asymptomatic to severe or lethal, the underlying mechanisms are not fully understood. It is likely that unique individual characteristics can strongly influence the broad disease variability; thus, tailored diagnostic and therapeutic approaches are needed to improve clinical outcomes. The circadian clock is a critical regulatory mechanism orchestrating major physiological and pathological processes. It is generally accepted that more than half of the cell-specific genes in any given organ are under circadian control. Although it is known that a specific role of the circadian clock is to coordinate the immune system's steady-state function and response to infectious threats, the links between the circadian clock and SARS-CoV-2 infection are only now emerging. How inter-individual variability of the circadian profile and its dysregulation may play a role in the differences noted in the COVID-19-related disease presentations, and outcome remains largely underinvestigated. This review summarizes the current evidence on the potential links between circadian clock dysregulation and SARS-CoV-2 infection susceptibility, disease presentation and progression, and clinical outcomes. Further research in this area may contribute towards novel circadian-centred prognostic, diagnostic and therapeutic approaches for COVID-19 in the era of precision health.

Indexed as

Circadian ClocksCOVID-19TicksAnimalsSARS-CoV-2circadian clockclinical outcomesCOVID-19epigeneticsmicroRNAsoral and systemic precision healthpersonalized medicineSARS-CoV-2 infection

Identifiers

PMID36394205
PMCPMC9670202
OpenAlexW4309514213

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.